191 related articles for article (PubMed ID: 21844889)
61. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
[TBL] [Abstract][Full Text] [Related]
62. PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.
Giovacchini G; Giovannini E; Leoncini R; Riondato M; Ciarmiello A
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1751-1776. PubMed ID: 28409220
[TBL] [Abstract][Full Text] [Related]
63. Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view.
Schiavina R; Brunocilla E; Borghesi M; Vagnoni V; Castellucci P; Nanni C; Ceci F; Gacci M; Martorana G; Fanti S
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):310-3. PubMed ID: 23933383
[TBL] [Abstract][Full Text] [Related]
64. Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake.
Balogova S; Huchet V; Egrot C; Michaud L; Paycha F; Kerrou K; Montravers F; Cussenot O; Talbot JN
Clin Nucl Med; 2013 Mar; 38(3):200-2. PubMed ID: 23354033
[TBL] [Abstract][Full Text] [Related]
65. PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.
Mertens K; Slaets D; Lambert B; Acou M; De Vos F; Goethals I
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2188-93. PubMed ID: 20544193
[TBL] [Abstract][Full Text] [Related]
66. 18F-Choline PET/MR Can Detect and Delineate Local Recurrence After High-Intensity Focused Ultrasound Therapy of Prostate Cancer.
Burger IA; Gafita A; Müller J; Kranzbühler B; Donati OF; Eberli D
Clin Nucl Med; 2018 Apr; 43(4):e111-e112. PubMed ID: 29432339
[TBL] [Abstract][Full Text] [Related]
67. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.
Schillaci O; Calabria F; Tavolozza M; Cicciò C; Carlani M; Caracciolo CR; Danieli R; Orlacchio A; Simonetti G
Nucl Med Commun; 2010 Jan; 31(1):39-45. PubMed ID: 19972635
[TBL] [Abstract][Full Text] [Related]
68. Bench to Bedside Development of [
Challapalli A; Barwick TD; Dubash SR; Inglese M; Grech-Sollars M; Kozlowski K; Tam H; Patel NH; Winkler M; Flohr P; Saleem A; Bahl A; Falconer A; De Bono JS; Aboagye EO; Mangar S
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138508
[TBL] [Abstract][Full Text] [Related]
69. Bio-Distribution, Imaging Protocols and Diagnostic Accuracy of PET with Tracers of Lipogenesis in Imaging Prostate Cancer: a Comparison between 11C-Choline, 18FFluoroethylcholine and 18F-Methylcholine.
Calabria F; Gallo G; Schillaci O; Cascini GL
Curr Pharm Des; 2015; 21(32):4738-47. PubMed ID: 26283228
[TBL] [Abstract][Full Text] [Related]
70. ¹⁸F-fluoromethylcholine or ¹⁸F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revision.
Evangelista L; Cervino AR; Guttilla A; Zattoni F; Cuccurullo V; Mansi L
Nucl Med Biol; 2015 Apr; 42(4):340-8. PubMed ID: 25618796
[TBL] [Abstract][Full Text] [Related]
71. PET/CT in prostate cancer: non-choline radiopharmaceuticals.
Castellucci P; Jadvar H
Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):367-74. PubMed ID: 23013666
[TBL] [Abstract][Full Text] [Related]
72. Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
Vali R; Loidl W; Pirich C; Langesteger W; Beheshti M
Am J Nucl Med Mol Imaging; 2015; 5(2):96-108. PubMed ID: 25973332
[TBL] [Abstract][Full Text] [Related]
73. Isolated cerebellar metastasis from prostate adenocarcinoma diagnosed by 18F-fluorocholine PET/CT: a rare but not impossible complication.
Imperiale A; Bergerat JP; Saussine C; Abu Eid M; Kehrli P; Namer IJ
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):397-8. PubMed ID: 24081449
[No Abstract] [Full Text] [Related]
74. Incidental Neurofibroma on 18F-Fluorocholine PET/MR.
Agrawal K; Sajjan RS; Gavra M; Fraioli F; Bomanji J; Syed R
Clin Nucl Med; 2015 Sep; 40(9):e455-6. PubMed ID: 26018694
[TBL] [Abstract][Full Text] [Related]
75. Skeletal "Superscan" on 18F-Choline PET/CT: Cases of Myeloproliferative Disease.
Dias AH; Bouchelouche K
Clin Nucl Med; 2016 Mar; 41(3):e173-4. PubMed ID: 26595339
[TBL] [Abstract][Full Text] [Related]
76.
Silveira MB; Rodrigues DM; Araújo MR; Santiago MA; Gonçalves NT; Schirmer BGA; Carneiro MM; Reis FM; Malamut C; Ferreira MC
Reprod Sci; 2018 Jan; 25(1):19-25. PubMed ID: 28874105
[TBL] [Abstract][Full Text] [Related]
77. Iodinated Choline Transport-Targeted Tracers.
Švec P; Nový Z; Kučka J; Petřík M; Sedláček O; Kuchař M; Lišková B; Medvedíková M; Kolouchová K; Groborz O; Loukotová L; Konefał RŁ; Hajdúch M; Hrubý M
J Med Chem; 2020 Dec; 63(24):15960-15978. PubMed ID: 33271015
[TBL] [Abstract][Full Text] [Related]
78. 18F-Fluorocholine Uptake by a Head and Neck Meningeal Inflammatory Pseudotumor.
Savelli G; Morassi M; Cobelli M; Stefanelli A; Zaniboni A
Clin Nucl Med; 2019 Aug; 44(8):657-659. PubMed ID: 31274616
[TBL] [Abstract][Full Text] [Related]
79. Radiosynthesis and pre-clinical evaluation of [(18)F]fluoro-[1,2-(2)H(4)]choline.
Smith G; Zhao Y; Leyton J; Shan B; Nguyen QD; Perumal M; Turton D; Årstad E; Luthra SK; Robins EG; Aboagye EO
Nucl Med Biol; 2011 Jan; 38(1):39-51. PubMed ID: 21220128
[TBL] [Abstract][Full Text] [Related]
80. ¹⁸F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer.
Lord M; Ratib O; Vallée JP
Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2288. PubMed ID: 21573978
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
